Neurodegenerative Diseases
Original Paper
Prevalence and Effects of Lobar Microhemorrhages in Early-Stage DementiaAtri A.a · Locascio J.J.a · Lin J.M.a · Yap L.a · Dickerson B.C.a, b · Grodstein F.b · Irizarry M.C.a · Growdon J.H.a · Greenberg S.M.aDepartments of Neurology,aMassachusetts General Hospital and bBrigham and Women’s Hospital, Harvard Medical School, Boston, Mass., USA
|
|
Log in to MyKarger to check if you already have access to this content.
KAB
Buy a Karger Article Bundle (KAB) and profit from a discount!
If you would like to redeem your KAB credit, please log in.
Save over 20% compared to the individual article price.
Article / Publication Details
Published online: May 05, 2006
Issue release date: May 2006
Number of Print Pages: 8
Number of Figures: 2
Number of Tables: 2
ISSN: 1660-2854 (Print)
eISSN: 1660-2862 (Online)
For additional information: https://www.karger.com/NDD
Abstract
Background: 80–100% of patients with Alzheimer’s disease have vascular pathology related to cerebral amyloid angiopathy (CAA), and 5–7% have CAA-related lobar microhemorrhages (LMH) at autopsy. The prevalence and effects of LMH detectable by gradient echo MRI (GE-MRI) in early-stage dementia are unknown. Objective: To obtain, using GE-MRI, a prevalence estimate for LMH in patients with early-stage dementia and to assess the effects of LMH on dementia severity. Methods: Eighty-four subjects aged ≧55 years (range 58–89; mean 76) underwent cognitive and GE-MRI evaluation. The 84 subjects consisted of 61 consecutive subjects evaluated as part of an initial clinical evaluation for dementia and 23 consecutively evaluated healthy older subjects (controls). Data were analyzed for presence and number of LMH on GE-MRI and the effect of number of LMH on dementia severity. Results: Nine (15%) of the 61 dementia patients versus 1 (4%) of the 23 control subjects demonstrated LMH on GE-MRI. Multiple (≧2) LMH were found in 7 of the 9 (88%) dementia subjects with LMH (range of LMH counts 1–330) and no (0%) control subjects. Multivariable causal modeling indicated that number of LMH (p < 0.02), age (p < 0.01) and duration of symptoms (p < 0.001) significantly increased dementia severity while higher educational level (p < 0.001) was protective. Conclusions: LMH were detected by GE-MRI in 15% of patients with early-stage dementia and may contribute to dementia severity.
© 2005 S. Karger AG, Basel
Related Articles:
References
- O’Brien JT, Erkinjuntti T, Reisberg B, Roman G, Sawada T, Pantoni L, Bowler JV, Ballard C, DeCarli C, Gorelick PB, Rockwood K, Burns A, Gauthier S, DeKosky ST: Vascular cognitive impairment. Lancet Neurol 2003;2:89–98.
- Koennecke HC: Cerebral microbleeds on MRI: prevalence, associations, and potential clinical implications. Neurology 2006;66:165–171.
- Knudsen KA, Rosand J, Karluk D, Greenberg SM: Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston Criteria. Neurology 2001;56:537–539.
- Greenberg SM, Gurol ME, Rosand J, Smith EE: Amyloid angiopathy-related vascular cognitive impairment. Stroke 2004;35(suppl 1):2616–2619.
- Jellinger KA: Alzheimer’s disease and cerebrovascular pathology: an update. J Neural Transm 2002;109:813–836.
- Ellis R, Olichney J, Thal L, Mirra S, Morris J, Beekly D, Heyman A: Cerebral amyloid angiopathy in the brains of patients with Alzheimer’s disease: the CERAD experience, part XV. Neurology 1996;46:1592–1596.
- Nakata Y, Shiga K, Yoshikawa K, Mizuno T, Mori S, Yamada K, Nakajima K: Subclinical brain hemorrhages in Alzheimer’s disease: evaluation by magnetic resonance T2*-weighted images. Ann NY Acad Sci 2002;977:169–172.
- Hanyu H, Tanaka Y, Shimizu S, Takasaki M, Abe K: Cerebral microbleeds in Alzheimer’s disease. J Neurol 2003;250:1496–1497.
- Roob G, Schmidt R, Kapeller P, Lechner A, Hartung HP, Fazekas F: MRI evidence of past cerebral microbleeds in a healthy elderly population. Neurology 1999;52:991–994.
- Tsushima Y, Tanizaki Y, Aoki J, Endo K: MR detection of microhemorrhages in neurologically healthy adults. Neuroradiology 2002;44:31–36.
- Jeerakathil T, Wolf PA, Beiser A, Hald JK, Au R, Kase CS, Massaro JM, DeCarli C: Cerebral microbleeds: prevalence and associations with cardiovascular risk factors in the Framingham Study. Stroke 2004;35:1831–1835.
- Fazekas F, Kleinert R, Roob G, Kleinert G, Kapeller P, Schmidt R, Hartung H-P: Histopathologic analysis of foci of signal loss on gradient-echo T2*-weighted MR images in patients with spontaneous intracerebral hemorrhage: evidence of microangiopathy-related microbleeds. AJNR Am J Neuroradiol 1999;20:637–642.
- Greenberg SM, O’Donnell HC, Schaefer PW, Kraft E: MRI detection of new hemorrhages: potential marker of progression in cerebral amyloid angiopathy. Neurology 1999;53:1135–1138.
- Locascio JJ, Lee J, Meltzer HY: Importance of adjusting for correlated concomitant variables in psychiatric research. Psychiatry Res 1988;23:311–327.
- Horwitz B, Tagamets MA: Predicting human functional maps with neural net modeling. Hum Brain Mapp 1999;8:137–142.
- Grady CL, McIntosh AR, Craik FI: Age-related differences in the functional connectivity of the hippocampus during memory encoding. Hippocampus 2003;13:572–586.
- Werring DJ, Frazer DW, Coward LJ, Losseff NA, Watt H, Cipolotti L, Brown MM, Jager HR: Cognitive dysfunction in patients with cerebral microbleeds on T2*-weighted gradient-echo MRI. Brain 2004;127:2265–2275.
- Pfeifer M, Boncristiano S, Bondolfi L, Stalder A, Deller T, Staufenbiel M, Mathews PM, Jucker M: Cerebral hemorrhage after passive anti-abeta immunotherapy. Science 2002;298(5597):1379.
- Racke MM, Boone LI, Hepburn DL, Parsadainian M, Bryan MT, Ness DK, Piroozi KS, Jordan WH, Brown DD, Hoffman WP, Holtzman DM, Bales KR, Gitter BD, May PC, Paul SM, DeMattos RB: Exacerbation of cerebral amyloid angiopathy-associated microhemorrhage in amyloid precursor protein transgenic mice by immunotherapy is dependent on antibody recognition of deposited forms of amyloid beta. J Neurosci 2005;25:629–636.
Article / Publication Details
Published online: May 05, 2006
Issue release date: May 2006
Number of Print Pages: 8
Number of Figures: 2
Number of Tables: 2
ISSN: 1660-2854 (Print)
eISSN: 1660-2862 (Online)
For additional information: https://www.karger.com/NDD
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
Get Permission
PubMed ID
